日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD(+) Therapy in HFpEF.

心脏具有内在的生酮能力,可介导 HFpEF 中的 NAD(+) 疗法

Koay Yen Chin, McIntosh Bailey, Ng Yann Huey, Cao Yang, Wang Xiao Suo, Han Yanchuang, Tomita Saki, Bai Angela Yu, Hunter Benjamin, Misra Ashish, Loughrey Christopher M, Bannon Paul G, Lal Sean, Lusis Aldons J, Kaye David M, Larance Mark, O'Sullivan John F

The Efficacy of Risk Factor Modification Compared to NAD(+) Repletion in Diastolic Heart Failure

风险因素修正与 NAD(+) 补充治疗在舒张性心力衰竭中的疗效比较

Koay, Yen Chin; Liu, Ren Ping; McIntosh, Bailey; Vigder, Niv; Lauren, Serlin; Bai, Angela Yu; Tomita, Saki; Li, Desmond; Harney, Dylan; Hunter, Benjamin; Zhang, Yunwei; Yang, Jean; Bannon, Paul; Philp, Ashleigh; Philp, Andrew; Kaye, David M; Larance, Mark; Lal, Sean; O'Sullivan, John F